Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The First Bladder Cancer Targeted Therapy Filed the Import Drug Clinical Trial Applications to Start the Road of Marketing in China

PharmaSources/XiaoyaowanDecember 04, 2019

Tag: Bladder cancer , targeted therapy , Erdafitini Tablets

PharmaSources Customer Service